HEADER HYDROLASE 23-OCT-96 1HAV TITLE HEPATITIS A VIRUS 3C PROTEINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATITIS A VIRUS 3C PROTEINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PICORNAIN 3C; COMPND 5 EC: 2.7.7.48; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HEPATITIS A VIRUS 3C PROTEINASE; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: PICORNAIN 3C; COMPND 12 EC: 2.7.7.48; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS A VIRUS; SOURCE 3 ORGANISM_TAXID: 12092; SOURCE 4 GENE: 3C; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PHAV-3CEX; SOURCE 8 EXPRESSION_SYSTEM_GENE: 3C; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HEPATITIS A VIRUS; SOURCE 11 ORGANISM_TAXID: 12092; SOURCE 12 GENE: 3C; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 EXPRESSION_SYSTEM_PLASMID: PHAV-3CEX; SOURCE 16 EXPRESSION_SYSTEM_GENE: 3C KEYWDS POLYPROTEIN, COAT PROTEIN, CORE PROTEIN, RNA-DIRECTED RNA POLYMERASE, KEYWDS 2 HYDROLASE, THIOL PROTEASE EXPDTA X-RAY DIFFRACTION AUTHOR E.M.BERGMANN,M.N.G.JAMES REVDAT 3 13-JUL-11 1HAV 1 VERSN REVDAT 2 24-FEB-09 1HAV 1 VERSN REVDAT 1 23-DEC-96 1HAV 0 JRNL AUTH E.M.BERGMANN,S.C.MOSIMANN,M.M.CHERNAIA,B.A.MALCOLM,M.N.JAMES JRNL TITL THE REFINED CRYSTAL STRUCTURE OF THE 3C GENE PRODUCT FROM JRNL TITL 2 HEPATITIS A VIRUS: SPECIFIC PROTEINASE ACTIVITY AND RNA JRNL TITL 3 RECOGNITION. JRNL REF J.VIROL. V. 71 2436 1997 JRNL REFN ISSN 0022-538X JRNL PMID 9032381 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.M.BERGMANN REMARK 1 TITL HEPATITIS A VIRUS PICORNAIN 3C REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH M.ALLAIRE,M.M.CHERNAIA,B.A.MALCOLM,M.N.JAMES REMARK 1 TITL PICORNAVIRAL 3C CYSTEINE PROTEINASES HAVE A FOLD SIMILAR TO REMARK 1 TITL 2 CHYMOTRYPSIN-LIKE SERINE PROTEINASES REMARK 1 REF NATURE V. 369 72 1994 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 3 REMARK 1 AUTH B.A.MALCOLM,S.M.CHIN,D.A.JEWELL,J.R.STRATTON-THOMAS, REMARK 1 AUTH 2 K.B.THUDIUM,R.RALSTON,S.ROSENBERG REMARK 1 TITL EXPRESSION AND CHARACTERIZATION OF RECOMBINANT HEPATITIS A REMARK 1 TITL 2 VIRUS 3C PROTEINASE REMARK 1 REF BIOCHEMISTRY V. 31 3358 1992 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.0 REMARK 3 NUMBER OF REFLECTIONS : 20059 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 11.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1958 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 67.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1504 REMARK 3 BIN R VALUE (WORKING SET) : 0.2770 REMARK 3 BIN FREE R VALUE : 0.3450 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 174 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3322 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 107 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.79 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.64 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 MAXIMUM LIKELIHOOD VERSION OF X-PLOR USED INSTEAD OF REMARK 3 CRYSTALLOGRAPHIC RESIDUAL, SEE PANNU N.S. AND READ R.J. REMARK 3 (1996) ACTA CRYST, VOL.A50, PP.659-668 REMARK 3 RESIDUES 147 - 151 IN BOTH MOLECULES, A AND B, ARE POORLY REMARK 3 DEFINED AND PRESUMABLY FLEXIBLE. REMARK 3 REMARK 3 RESIDUES 147 - 151 IN BOTH MOLECULES, A AND B, ARE POORLY REMARK 3 DEFINED AND PRESUMABLY FLEXIBLE. REMARK 3 REMARK 3 ASP A 36 AND ASP B 36: REMARK 3 UNUSUAL MAIN CHAIN CONFORMATIONAL ANGLES RESIDUE I+1 OF REMARK 3 II' REVERSE TURN AND WELL-DEFINED IN ELECTRON DENSITY REMARK 3 DESPITE BEING FLAGGED AN OUTLIER IN A RAMACHANDRAN PLOT. REMARK 4 REMARK 4 1HAV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-OCT-94 REMARK 200 TEMPERATURE (KELVIN) : 295 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : XUONG-HAMLIN MULTIWIRE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SDMS REMARK 200 DATA SCALING SOFTWARE : BIOMOL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25299 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.0 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.06730 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : 0.27130 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: INACTIVE DOUBLE MUTANT OF ALLAIRE ET AL. (1994), REMARK 200 SEE REFERENCE 2. REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 53.60000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ACTIVE SITE CYSTEINE 172 IS OXIDIZED IN MOLECULE B. REMARK 400 MOLECULE A RESEMBLES ACTIVE PROTEINASE. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 217 REMARK 465 LYS B 215 REMARK 465 ILE B 216 REMARK 465 GLU B 217 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 13 CA - CB - CG ANGL. DEV. = 15.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 29 -153.78 -162.52 REMARK 500 LYS A 35 140.55 -171.82 REMARK 500 ASP A 36 -115.09 47.06 REMARK 500 ASN A 114 -7.99 90.27 REMARK 500 LYS A 140 111.87 -167.58 REMARK 500 ASN A 148 99.59 -37.92 REMARK 500 ASP A 149 123.29 57.00 REMARK 500 GLN A 159 79.60 67.44 REMARK 500 LEU A 168 123.44 -174.73 REMARK 500 SER A 197 27.82 -164.46 REMARK 500 MET B 29 -169.32 -165.68 REMARK 500 ASP B 36 -113.58 43.98 REMARK 500 ASP B 51 78.79 -118.61 REMARK 500 ASP B 79 -79.65 -115.74 REMARK 500 VAL B 80 -24.63 -145.46 REMARK 500 PHE B 82 -8.70 -154.69 REMARK 500 ASP B 84 -69.61 -106.64 REMARK 500 LYS B 147 -39.39 -29.79 REMARK 500 ASN B 148 -89.76 -65.69 REMARK 500 ASP B 149 -53.75 -146.18 REMARK 500 GLN B 159 77.17 48.69 REMARK 500 ASN B 196 -79.67 -90.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 LYS B 47 25.0 L L OUTSIDE RANGE REMARK 500 LYS B 50 24.3 L L OUTSIDE RANGE REMARK 500 ASP B 84 23.9 L L OUTSIDE RANGE REMARK 500 ILE B 212 24.2 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: PRO REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CYS-HIS DYAD AND STABILIZING ELECTROSTATIC REMARK 800 ENVIRONMENT (CYS 172, HIS 44, TYR 143). REMARK 800 REMARK 800 SITE_IDENTIFIER: S1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: HIS 191 IN A POSITION TO HYDROGEN-BOND TO REMARK 800 GLUTAMINE RESIDUE IN P1 POSITION OF PEPTIDE SUBSTRATE. REMARK 800 REMARK 800 SITE_IDENTIFIER: RNA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CONSERVED SEQUENCE MOTIF KFRDI ON SURFACE REMARK 800 OPPOSITE FROM PROTEOLYTIC ACTIVE SITE (LYS 95 TO ILE 99). REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 218 DBREF 1HAV A 1 217 UNP P08617 POLG_HPAVH 1520 1736 DBREF 1HAV B 1 217 UNP P08617 POLG_HPAVH 1520 1736 SEQADV 1HAV SER A 24 UNP P08617 CYS 1543 ENGINEERED SEQADV 1HAV SER B 24 UNP P08617 CYS 1543 ENGINEERED SEQADV 1HAV OCS B 172 UNP P08617 CYS 1691 CONFLICT SEQRES 1 A 217 SER THR LEU GLU ILE ALA GLY LEU VAL ARG LYS ASN LEU SEQRES 2 A 217 VAL GLN PHE GLY VAL GLY GLU LYS ASN GLY SER VAL ARG SEQRES 3 A 217 TRP VAL MET ASN ALA LEU GLY VAL LYS ASP ASP TRP LEU SEQRES 4 A 217 LEU VAL PRO SER HIS ALA TYR LYS PHE GLU LYS ASP TYR SEQRES 5 A 217 GLU MET MET GLU PHE TYR PHE ASN ARG GLY GLY THR TYR SEQRES 6 A 217 TYR SER ILE SER ALA GLY ASN VAL VAL ILE GLN SER LEU SEQRES 7 A 217 ASP VAL GLY PHE GLN ASP VAL VAL LEU MET LYS VAL PRO SEQRES 8 A 217 THR ILE PRO LYS PHE ARG ASP ILE THR GLN HIS PHE ILE SEQRES 9 A 217 LYS LYS GLY ASP VAL PRO ARG ALA LEU ASN ARG LEU ALA SEQRES 10 A 217 THR LEU VAL THR THR VAL ASN GLY THR PRO MET LEU ILE SEQRES 11 A 217 SER GLU GLY PRO LEU LYS MET GLU GLU LYS ALA THR TYR SEQRES 12 A 217 VAL HIS LYS LYS ASN ASP GLY THR THR VAL ASP LEU THR SEQRES 13 A 217 VAL ASP GLN ALA TRP ARG GLY LYS GLY GLU GLY LEU PRO SEQRES 14 A 217 GLY MET CYS GLY GLY ALA LEU VAL SER SER ASN GLN SER SEQRES 15 A 217 ILE GLN ASN ALA ILE LEU GLY ILE HIS VAL ALA GLY GLY SEQRES 16 A 217 ASN SER ILE LEU VAL ALA LYS LEU VAL THR GLN GLU MET SEQRES 17 A 217 PHE GLN ASN ILE ASP LYS LYS ILE GLU SEQRES 1 B 217 SER THR LEU GLU ILE ALA GLY LEU VAL ARG LYS ASN LEU SEQRES 2 B 217 VAL GLN PHE GLY VAL GLY GLU LYS ASN GLY SER VAL ARG SEQRES 3 B 217 TRP VAL MET ASN ALA LEU GLY VAL LYS ASP ASP TRP LEU SEQRES 4 B 217 LEU VAL PRO SER HIS ALA TYR LYS PHE GLU LYS ASP TYR SEQRES 5 B 217 GLU MET MET GLU PHE TYR PHE ASN ARG GLY GLY THR TYR SEQRES 6 B 217 TYR SER ILE SER ALA GLY ASN VAL VAL ILE GLN SER LEU SEQRES 7 B 217 ASP VAL GLY PHE GLN ASP VAL VAL LEU MET LYS VAL PRO SEQRES 8 B 217 THR ILE PRO LYS PHE ARG ASP ILE THR GLN HIS PHE ILE SEQRES 9 B 217 LYS LYS GLY ASP VAL PRO ARG ALA LEU ASN ARG LEU ALA SEQRES 10 B 217 THR LEU VAL THR THR VAL ASN GLY THR PRO MET LEU ILE SEQRES 11 B 217 SER GLU GLY PRO LEU LYS MET GLU GLU LYS ALA THR TYR SEQRES 12 B 217 VAL HIS LYS LYS ASN ASP GLY THR THR VAL ASP LEU THR SEQRES 13 B 217 VAL ASP GLN ALA TRP ARG GLY LYS GLY GLU GLY LEU PRO SEQRES 14 B 217 GLY MET OCS GLY GLY ALA LEU VAL SER SER ASN GLN SER SEQRES 15 B 217 ILE GLN ASN ALA ILE LEU GLY ILE HIS VAL ALA GLY GLY SEQRES 16 B 217 ASN SER ILE LEU VAL ALA LYS LEU VAL THR GLN GLU MET SEQRES 17 B 217 PHE GLN ASN ILE ASP LYS LYS ILE GLU MODRES 1HAV OCS B 172 CYS CYSTEINESULFONIC ACID HET OCS B 172 9 HET CL B 218 1 HETNAM OCS CYSTEINESULFONIC ACID HETNAM CL CHLORIDE ION FORMUL 2 OCS C3 H7 N O5 S FORMUL 3 CL CL 1- FORMUL 4 HOH *107(H2 O) HELIX 1 1 THR A 2 ASN A 12 1 11 HELIX 2 2 SER A 43 TYR A 46 5 4 HELIX 3 3 TYR A 52 MET A 54 5 3 HELIX 4 4 ALA A 70 ASN A 72 5 3 HELIX 5 5 ILE A 99 HIS A 102 5 4 HELIX 6 6 LYS A 106 ARG A 111 5 6 HELIX 7 7 GLN A 181 ILE A 183 5 3 HELIX 8 8 GLN A 206 ASP A 213 5 8 HELIX 9 9 THR B 2 ASN B 12 1 11 HELIX 10 10 SER B 43 ALA B 45 5 3 HELIX 11 11 ALA B 70 ASN B 72 5 3 HELIX 12 12 THR B 100 HIS B 102 5 3 HELIX 13 13 LYS B 106 ARG B 111 5 6 HELIX 14 14 GLN B 181 ILE B 183 5 3 HELIX 15 15 GLN B 206 ASN B 211 5 6 SHEET 1 A 7 THR A 64 SER A 69 0 SHEET 2 A 7 GLU A 56 ARG A 61 -1 N PHE A 59 O TYR A 66 SHEET 3 A 7 LEU A 13 GLY A 19 -1 N GLY A 19 O GLU A 56 SHEET 4 A 7 VAL A 25 LYS A 35 -1 N ALA A 31 O VAL A 14 SHEET 5 A 7 TRP A 38 PRO A 42 -1 N LEU A 40 O LEU A 32 SHEET 6 A 7 VAL A 85 LYS A 89 -1 N MET A 88 O LEU A 39 SHEET 7 A 7 VAL A 74 SER A 77 -1 N GLN A 76 O LEU A 87 SHEET 1 B 7 THR A 126 GLU A 132 0 SHEET 2 B 7 ALA A 117 VAL A 123 -1 N VAL A 123 O THR A 126 SHEET 3 B 7 ALA A 175 SER A 178 -1 N VAL A 177 O THR A 118 SHEET 4 B 7 ILE A 187 GLY A 194 -1 N GLY A 189 O LEU A 176 SHEET 5 B 7 ILE A 198 LEU A 203 -1 N LYS A 202 O ILE A 190 SHEET 6 B 7 ALA A 160 LYS A 164 -1 N GLY A 163 O LEU A 199 SHEET 7 B 7 LYS A 136 GLU A 138 -1 N GLU A 138 O ALA A 160 SHEET 1 C 2 LYS A 140 LYS A 146 0 SHEET 2 C 2 THR A 152 ASP A 158 -1 N VAL A 157 O ALA A 141 SHEET 1 D 7 TYR B 65 SER B 69 0 SHEET 2 D 7 GLU B 56 ARG B 61 -1 N PHE B 59 O TYR B 66 SHEET 3 D 7 LEU B 13 GLY B 19 -1 N GLY B 19 O GLU B 56 SHEET 4 D 7 ARG B 26 LYS B 35 -1 N ALA B 31 O VAL B 14 SHEET 5 D 7 TRP B 38 PRO B 42 -1 N LEU B 40 O LEU B 32 SHEET 6 D 7 VAL B 85 LYS B 89 -1 N MET B 88 O LEU B 39 SHEET 7 D 7 VAL B 74 GLN B 76 -1 N GLN B 76 O LEU B 87 SHEET 1 E 7 THR B 126 GLU B 132 0 SHEET 2 E 7 ALA B 117 VAL B 123 -1 N VAL B 123 O THR B 126 SHEET 3 E 7 ALA B 175 SER B 178 -1 N VAL B 177 O THR B 118 SHEET 4 E 7 ILE B 187 GLY B 194 -1 N GLY B 189 O LEU B 176 SHEET 5 E 7 ILE B 198 LEU B 203 -1 N LYS B 202 O ILE B 190 SHEET 6 E 7 ALA B 160 LYS B 164 -1 N GLY B 163 O LEU B 199 SHEET 7 E 7 LYS B 136 GLU B 138 -1 N GLU B 138 O ALA B 160 SHEET 1 F 2 LYS B 140 HIS B 145 0 SHEET 2 F 2 VAL B 153 ASP B 158 -1 N VAL B 157 O ALA B 141 LINK N OCS B 172 C MET B 171 1555 1555 1.33 LINK C OCS B 172 N GLY B 173 1555 1555 1.33 SITE 1 PRO 4 CYS A 172 HIS A 44 TYR A 143 HOH A 223 SITE 1 S1 4 HIS A 191 GLU A 132 HOH A 221 HOH A 226 SITE 1 RNA 4 LYS A 95 ARG A 97 ASP A 98 HOH A 223 SITE 1 AC1 2 ILE A 75 THR B 2 CRYST1 53.600 53.550 53.200 99.08 129.00 103.31 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018657 0.004414 0.018414 0.00000 SCALE2 0.000000 0.019190 0.008381 0.00000 SCALE3 0.000000 0.000000 0.026394 0.00000 MTRIX1 1 0.880800 -0.466100 -0.083200 -17.55410 1 MTRIX2 1 0.251200 0.311300 0.916500 -26.85540 1 MTRIX3 1 -0.401300 -0.828200 0.391300 18.58400 1 MASTER 363 0 2 15 32 0 4 9 0 0 0 34 END